Rosiglitazone reverses cardiac adverse remodeling (fibrosis and vascularization) in perinatal low protein rat offspring. (Q43071641)
Jump to navigation
Jump to search
scientific article published on 5 May 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Rosiglitazone reverses cardiac adverse remodeling (fibrosis and vascularization) in perinatal low protein rat offspring. |
scientific article published on 5 May 2010 |
Statements
Rosiglitazone reverses cardiac adverse remodeling (fibrosis and vascularization) in perinatal low protein rat offspring (English)
Thiago da Silva Torres
Marcia Barbosa Aguila